MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabres

MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis ...

Related Keywords

Germany , Massachusetts , United States , Munich , Bayern , Planegg , Illinois , Boston , Chicago , American , Myelofibrosis , Nealysenior Directortel , Julia Neugebauervice , Twitter , Linkedin , Lymphoma Society , News Network , American Society Of Clinical Oncology , Constellation Pharmaceuticals Inc , Sys To Present New Phase , Clinical Oncology , Efficacy Data , Combination With Ruxolitinib , Patients With Myelofibrosis , Advanced Solid Tumors , Morphosys At , Pelabresib , Thomas Biegisenior Vice President , Corporate Affairstel , Julia Neugebauervice President , Global Head , Investor Relationstel , Senior Directortel ,